Evaluation of recurrence and survival rate of transoral laser microsurgery for laryngeal cancer at National Otolaryngology Hospital

  • Nguyen Quang Trung Hanoi Medical University
  • Thai Ba Manh Hanoi Medical University
  • Bui The Anh Central Ear, Nose and Throat Hospital

Main Article Content

Keywords

Early-stage laryngeal cancer, transoral laser microsurgery, CO2 laser

Abstract

Objective: To evaluate local recurrence, cervical lymph node metastasis, distant metastasis and survival rate of laryngeal cancer patients after transoral laser microsurgery (TLM). Subject and method: Retrospective cohort study of 345 patients with laryngeal cancer treated by TLM at Oncology-Head and Neck surgery Center, National Otolaryngology Hospital from January 2012 to December 2021. Result: Recurrent rate was 12.2%, average recurrent time was 26.1 months; Disease-free survival time ranged from 97.6-112.3 months, disease-free survival rate after 3 years was 86.5%, after 5 years was 85%, overall survival time ranged from 105.4-114.9 months, overall survival rate after 3 years was 97%, after 5 years was 82%. Conclusion: TLM was highly effective in treating early-stage laryngeal cancer with excellent survival rate, few complications and low recurrent rate.

Article Details

References

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin Nov 68(6): 394-424.
2. Harrison LB, Sessions RB, Kies MS (2009) Chapter 15: Early stage cancer of the larynx. Head and Neck Cancer - A Multidisplinary Approach, 3rd edition, Lippincott Williams & Wilkins, Philadelphia: 339-366.
3. Strong MS, Jako GJ (1972) Laser surgery in the larynx: Early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol 81(6): 791-798.
4. Silver CE, Beitler JJ, Shaha AR et al (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266(9): 1333-1352.
5. Piazza C, Paderno A, Bon F et al (2021) Long-term oncologic outcomes of 1188 Tis-T2 glottic cancers treated by transoral laser microsurgery. Otolaryngol Head Neck Surg 165(2): 321-328.
6. Galli A, Giordano L, Sarandria D et al (2016) Oncological and complication assessment of CO2 laser-assisted endoscopic surgery for T1-T2 glottic tumours: Clinical experience. Acta Otorhinolaryngol Ital 36(3): 167-173.
7. Rodel RMW, Steiner W, Muller RM et al (2009) Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck 31(5): 583-592.
8. Hakeem AH, Tubachi J, Pradhan SA et al (2013) Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans-oral CO2 laser microsurgery. Laryngoscope 123(8): 1912-1917.
9. Sigston E, de Mones E, Babin E et al (2006) Early-stage glottic cancer: Oncological results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg 132(2): 147-152. doi:10.1001/archotol.132.2.147
10. Breda E, Catarino R, Monteiro E (2015) Transoral laser microsurgery for laryngeal carcinoma: Survival analysis in a hospital-based population. Head Neck 37(8): 1181-1186.
11. Batra A, Goyal A, Goyal M et al (2019) Oncological Outcomes Following Transoral CO2 Laser Microsurgery for T1 Glottic Cancer. Indian J Otolaryngol Head Neck Surg 71(1): 542-547.
12. Peretti G (2001) Oncological results of endoscopic resections of Tis and T1 glottic carcinomas by carbon dioxide laser. Ann Otol Rhinol Laryngol 110(9): 820-826.
13. De Seta D, Campo F, D’Aguanno V et al (2021) Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up. Lasers Med Sci 36(3): 507-512. doi:10.1007/s10103-020-03049-4.